Sign Up For Updates
My RWC:  

Session 5: Macular Trials: the Good, the Bad, and the Ugly

October 24, 2021

Learning Objectives

  • Describe how clinical trial results differentiate treatments based on functional, anatomic, and visual outcomes
  • Sequence and combine therapies appropriately based on response to anti-VEGF and other patient-specific factors
  • Evaluate innovative therapies and delivery systems based on their ability to improve durability and maintain visual outcomes
  • Use imaging to diagnose patients with dry AMD and differentiate GA from other forms of AMD
  • Identify patients who would be suitable candidates for gene-replacement therapy

This event has concluded.